| rTMS for Stimulant Use Disorders (NCT04907357) | Medical University of South Carolina | 2022-02-04 |
| Cocaine and Zolmitriptan (NCT05019430) | William Stoops | 2021-10-15 |
| Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention (NCT04843046) | The University of Texas Health Science Center, Houston | 2021-08-23 |
| Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056 (NCT04771143) | Novartis Pharmaceuticals | 2021-07-21 |
| Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study (NCT04721418) | Yale University | 2021-07-20 |
| Exenatide for Treating Cocaine Use Disorder (NCT04941521) | The University of Texas Health Science Center, Houston | 2021-06-24 |
| Improvement of Cocaine Use Disorder Treatment Through Cognitive Behavioral Therapy Web-based Treatment (CBT4CBT) (NCT05207228) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2021-04-12 |
| Virtual Reality Exposure and Respiratory Relaxation-Based Coping With Cocaine Craving in Cocaine Users (NCT05557149) | Laboratoire de Psychologie des Cognitions | 2021-03-31 |
| [C-11]NPA PET-amphetamine in Cocaine Use Disorders (NCT05011760) | Rajesh Narendran | 2021-01-31 |
| Neurobehavioral Mechanisms of Cocaine Choice (NCT04296006) | Joshua A. Lile, Ph.D. | 2021-01-15 |
| Imaging CRF X NOP Interactions in CUD (NCT05008146) | Rajesh Narendran | 2020-12-31 |
| A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder (NCT04501874) | Embera NeuroTherapeutics, Inc. | 2020-07-29 |
| Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project (NCT03799341) | VA Office of Research and Development | 2019-11-13 |
| The Effect of Self-Forgiveness on Self-Stigma in Addiction. (NCT03971097) | University of Pittsburgh | 2019-08-01 |
| Suvorexant and Cocaine (NCT03937986) | William Stoops | 2019-07-11 |
| Vitamin D and Cocaine Administration (NCT04826133) | Yale University | 2019-03-27 |
| TDCS for Cocaine Addiction Craving (NCT03833583) | Soterix Medical | 2019-02-01 |
| Imagery-based Coping for Cocaine Use Disorder (NCT03656653) | King's College London | 2018-10-30 |
| Feasibility and Validation of a Standard Phenotyping Assessment Battery (NCT03495869) | Virginia Commonwealth University | 2018-06-21 |
| Behavioral Effects of Drugs: Inpatient (35) (NCT03519022) | Craig Rush | 2018-06-01 |
| Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder (NCT03430544) | Anna Rose Childress, Ph.D. | 2018-04-04 |
| Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations (NCT03404817) | Embera NeuroTherapeutics, Inc. | 2018-03-01 |
| Efficacy of Repetitive Transcranial Magnetic Stimulation in Reducing Cocaine Intake in Addicted Patients (NCT03607591) | Azienda Ospedaliero-Universitaria Careggi | 2018-01-08 |
| Treatment With Lorcaserin for Cocaine Use: The TLC Study (NCT03192995) | Glenn-Milo Santos | 2018-01-01 |
| Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders (NCT03344419) | New York State Psychiatric Institute | 2017-10-01 |
| Cocaine Use Reduction and Health (NCT03224546) | William Stoops | 2017-09-15 |
| Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting (NCT03662529) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2017-06-05 |
| Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use (NCT02927236) | National Institute on Drug Abuse (NIDA) | 2017-02-13 |
| A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine (NCT02856854) | Embera NeuroTherapeutics, Inc. | 2016-07-01 |
| Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use (NCT02785406) | The University of Texas Health Science Center, Houston | 2016-05-01 |
| Trial Of NS2359 For The Treatment of Cocaine Dependence (NCT02798627) | University of Pennsylvania | 2016-05-01 |
| Navigation Services to Avoid Rehospitalization (NavSTAR) (NCT02599818) | Friends Research Institute, Inc. | 2016-03-15 |
| Methylphenidate-Duloxetine Combinations for Cocaine Dependence (NCT02700711) | University of Kentucky | 2016-02-01 |
| Reinforcing Effects of Cocaine During Phendimetrazine Maintenance (NCT02522325) | William Stoops | 2015-08-01 |
| Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder (NCT02537873) | Virginia Commonwealth University | 2015-07-01 |
| Neural Substrates of Emotion: Impact of Cocaine Dependence (NCT02682784) | Medical University of South Carolina | 2015-07-01 |
| A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use (NCT02444208) | University of Kentucky | 2015-05-01 |
| The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT) (NCT02174614) | Yale University | 2015-04-01 |
| Predicting Relapse After Cocaine Inpatient Cessation (NCT02416050) | Assistance Publique - Hôpitaux de Paris | 2015-02-03 |
| Subjective Sleep Quality in CUD TMS-Treated (NCT03733821) | Fondazione Novella Fronda | 2015-01-01 |
| [11C]NOP-1A and Cocaine Use Disorders (NCT03348384) | University of Pittsburgh | 2014-10-30 |
| Treatment Outcome in CBT for Cocaine Use (NCT03538548) | New York State Psychiatric Institute | 2014-09-30 |
| Topiramate-Phentermine Combinations for Cocaine Dependence (NCT02239913) | University of Kentucky | 2014-09-01 |
| Phendimetrazine and Cocaine (NCT02233647) | William Stoops | 2014-09-01 |
| Extending Long-term Outcomes Through an Adaptive Aftercare Intervention (NCT02143063) | UConn Health | 2014-08-01 |
| Cocaine Opioid Oxytocin Option - Limited (NCT02028533) | University of California, San Francisco | 2014-07-01 |
| Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study (NCT01684293) | University of California, San Francisco | 2013-07-01 |
| PPARγ Agonist Treatment for Cocaine Dependence (NCT02774343) | The University of Texas Health Science Center, Houston | 2012-08-01 |